Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Therapeutic Drug Monitoring

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.FTD.0000197091.07807.22PMID 16628124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimating Time of Last Oral Ingestion of Cannabis From Plasma THC and THCCOOH Concentrations

  2006cited by this paper
• Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.

  2006cited by this paper
• Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.

  2005cited by this paper
• Cannabinoids in hair: strategy to prove marijuana/hashish consumption.

  2004influential reference
• An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.

  2004cited by this paper
• Pharmacokinetics and Pharmacodynamics of Cannabinoids

  2003cited by this paper
• Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.

  2003cited by this paper
• Urinary excretion profiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol: a Δ9-THC-COOH to creatinine ratio study #2

  2003cited by this paper
• Urinary excretion profiles of 11-nor-9-carboxy-? 9-tetrahydrocannabinol

  2003cited by this paper
• Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.

  2003cited by this paper
• Absolute Fahruntuechtigkeit unter der Wirkung von Cannabis. Vorschlag fuer einen Grenzwert / Absolute driving inability under the influence of cannabis. Proposal for a threshold limit

  2003cited by this paper
• Hair analysis for delta(9)-THC, delta(9)-THC-COOH, CBN and CBD, by GC/MS-EI. Comparison with GC/MS-NCI for delta(9)-THC-COOH.

  2002cited by this paper
• Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analyses.

  2002cited by this paper
• Stability of 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry.

  2002cited by this paper
• The determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair using negative ion gas chromatography-mass spectrometry and high-volume injection.

  2001cited by this paper
• Temporal Indication of Marijuana Use Can Be Estimated From Plasma and Urine Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, and 11-Nor-Δ9-Tetrahydrocannabinol-9-Carboxylic Acid

  2001cited by this paper
• Time of drug elimination in chronic drug abusers. Case study of 52 patients in a "low-step" detoxification ward.

  2001cited by this paper
• Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.

  2001cited by this paper
• Δ9-THC, 11-OH-Δ9-THC and Δ9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people

  2001cited by this paper
• Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.

  2001cited by this paper
• Simultaneous Determination of Δ9-Tetrahydrocannabinol and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Human Plasma by Solid-Phase Extraction and Gas Chromatography-Negative Ion Chemical Ionization-Mass Spectrometry

  2001cited by this paper
• Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.

  2001cited by this paper
• Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.

  2001cited by this paper
• Tandem mass spectrometry: a helpful tool in hair analysis for the forensic expert.

  2000cited by this paper
• Detection of THCCOOH in hair by MSD-NCI after HPLC clean-up.

  2000cited by this paper
• Tandem mass spectrometry: a helpful tool in hair analysis for the forensic expert

  2000cited by this paper
• Deciding between one off/occasional and regular cannabis consumption

  2000cited by this paper
• Entscheidung zwischen einmaligem/gelegentlichem und regelmaessigem Cannabiskonsum

  2000cited by this paper
• Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users.

  1999cited by this paper
• Urinary Excretion Profiles of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol: A Δ9-THCCOOH to Creatinine Ratio Study

  1999cited by this paper
• Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio study.

  1999cited by this paper
• Freie und glucuronidierte Cannabinoide im Urin – Untersuchungen zur Einschätzung des Konsumverhaltens

  1999cited by this paper
• Testing for drugs in hair. Critical review of chromatographic procedures since 1992.

  1998cited by this paper
• Differentiating new marijuana use from residual drug excretion in occasional marijuana users.

  1998cited by this paper
• Using hair analysis, urinalysis, and self-reports to estimate drug use in a sample of detained juveniles.

  1998cited by this paper
• Stability of cannabinoids in urine in three storage temperatures.

  1998cited by this paper
• Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.

  1998cited by this paper
• Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

  1996cited by this paper
• A research note: the outcome of GC/MS/MS confirmation of hair assays on 93 cannabinoid (+) cases.

  1995cited by this paper
• Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair.

  1995cited by this paper
• Detection times of marijuana metabolites in urine by immunoassay and GC-MS.

  1995cited by this paper
• Stability of drugs of abuse in urine samples stored at -20 degrees C.

  1994cited by this paper
• FAHREN UNTER DROGEN- ODER MEDIKAMENTENEINFLUSS. FORENSISCHE INTERPRETATION UND BEGUTACHTUNG

  1994cited by this paper
• Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

  1992influential reference
• Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)

  1992cited by this paper
• Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.

  1992cited by this paper
• [Urinary excretion of cannabis metabolites].

  1992cited by this paper
• Urinary excretion of cannabis metabolites

  1992cited by this paper
• Blood cannabinoids. II: Models for the prediction of time of marijuana exposure from plasma concentrations of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH)

  1992cited by this paper
• Importance of creatinine analyses of urine when screening for abused drugs.

  1991cited by this paper
• Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.

  1989cited by this paper
• Interpretation of urine quantitative 11-nor-delta-9 tetrahydrocannabinol-9-carboxylic acid to determine abstinence from marijuana smoking.

  1989cited by this paper
• Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.

  1989cited by this paper
• Determination of Δ1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography–mass spectrometry

  1989cited by this paper
• Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry.

  1989cited by this paper
• Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion.

  1988cited by this paper
• Pharmacokinetics and disposition of cannabinoids.

  1987cited by this paper
• The pharmacological activity of the fatty acid conjugate 11-palmitoyloxy-delta 9-tetrahydrocannabinol.

  1986cited by this paper
• Profiles of delta 9-tetrahydrocannabinol metabolites in urine of marijuana users: preliminary observations by high performance liquid chromatography-radioimmunoassay.

  1986cited by this paper
• Excretion patterns of cannabinoid metabolites after last use in a group of chronic users

  1985cited by this paper
• Cannabis: pharmacology and interpretation of effects.

  1985cited by this paper
• The cannabinoids: chemical, pharmacologic, and therapeutic aspects.

  1984cited by this paper
• URINE EXCRETION PATTERNS OF CANNABINOIDS AND THE CLINICAL APPLICATION OF THE EMIT-d.a.u. CANNABINOID URINE ASSAY FOR SUBSTANCE ABUSE TREATMENT

  1984cited by this paper
• Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin

  1984cited by this paper
• Quantitative measurement of delta 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry.

  1983cited by this paper
• Metabolism, disposition, and kinetics of delta‐9‐tetrahydrocannabinol in men and women

  1983influential reference
• Quantitative measurement of Δ9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry

  1983cited by this paper
• Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum.

  1983cited by this paper
• Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.

  1982cited by this paper
• Comparison of effects of marihuana cigarettes of three different potencies

  1982cited by this paper
• Persistence of urinary marijuana levels after supervised abstinence.

  1982cited by this paper
• Gas chromatographic and mass spectrometric studies on the metabolism and pharmacokinetics of delta 1-tetrahydrocannabinol in the rabbit.

  1982cited by this paper
• Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.

  1981cited by this paper
• Do Plasma Concentrations of Δ9‐Tetrahydrocannabinol Reflect the Degree of Intoxication?

  1981cited by this paper
• Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication?

  1981cited by this paper
• 125I radioimmunoassay of delta-9-tetrahydrocannabinol in blood and plasma with a solid-phase second-antibody separation method.

  1981cited by this paper
• Plasma delta‐9‐tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

  1980cited by this paper
• Tolerance and disposition of tetrahydrocannabinol in man.

  1980influential reference
• Laboratory Verification of "heavy" and "light" users of cannabis.

  1980cited by this paper
• Long-retained metabolites of delta9- and delta8-tetrahydrocannabinols identified as novel fatty acid conjugates.

  1976cited by this paper
• Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man.

  1974cited by this paper
• Binding of (+)‐ and (‐)‐Δ1‐tetrahydrocannabinols and (‐)‐7‐hydroxy‐Δ1‐tetrahydrocannabinol to blood cells and plasma proteins in man

  1974cited by this paper
• Delta-9-Tetrahydrocannabinol: Localization in Body Fat

  1973cited by this paper
• Delta-9-Tetrahydrocannabinol: Metabolism and Disposition in Long-Term Marihuana Smokers

  1971influential reference
• On the metabolism of tritium-labelled 1-tetrahydrocannabinol in the rabbit.

  1970cited by this paper
• Distribution of tritiated-1 delta 9tetrahydrocannabinol in rat tissues after inhalation.

  1970cited by this paper
• Binding of δ1-tetrahydrocannabinol to human plasma proteins☆

  1970cited by this paper
• Distribution of tritiated‐1 Δ9‐tetrahydrocannabinol in rat tissues after inhalation

  1970cited by this paper
• Binding of delta-1-tetrahydrocannabinol to human plasma proteins.

  1970cited by this paper

• Delta-9-Tetrahydrocannabinol (THC) Before Bedtime: Feasibility and Mechanistic Pilot Study on Sleep and Cardiac Autonomic Activity.

  2026cites this paper
• Something is not nothing: Hair-tested substance use and cognitive functions in a large community sample of young adults

  2026cites this paper
• Substance use assessment: comparing self-reports with objective data in a research setting

  2026cites this paper
• Cannabis use is associated with changes in psychological and functional well-being during young adulthood: evidence from self-reports and hair analyses

  2025cites this paper
• A Holistic Review of Cannabis and Its Potential Risks and Benefits in Mental Health

  2025cites this paper
• A Fine-Grained Longitudinal Study of Adolescent Cannabis Use and Its Relation to Cognitive Performance in Young Adulthood

  2025cites this paper
• Analytical Methods for the Determination of Diamorphine (Heroin) in Biological Matrices: A Review

  2025cites this paper
• Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders.

  2025cites this paper
• Analysis of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) on hair after single and repeated short in vivo passive exposures to low- and high-Δ9-THC-cannabis.

  2025cites this paper
• Collection of Δ9-tetrahydrocannabinol from breath by liquid secondary adsorption analyzed with mass spectrometry: a technical note

  2025cites this paper
• Cannabis use among young adults with acute coronary syndrome: impact on initial presentation and long-term prognosis

  2025cites this paper
• Current status of keratinized matrices in Toxicology: Comparison of hair and nails

  2024cites this paper
• Current chromatographic methods to determine cannabinoids in biological samples: a review of the state-of-the art on sample preparation techniques

  2024cites this paper
• Differential Mechanisms of Behavior Change in Cannabis Use Disorder Treatments: Functional Improvements and Clinical Implications

  2024cites this paper
• Cannabis hyperemesis syndrome: the rare case of a valid diagnosis plus hypersensitization hypothesis for development and chronification of this severe somatic cannabis use disorder

  2024cites this paper
• Review and Call for Improved Cannabis Measurement and the Potential for Leveraging Cannabis Seed-To-Sale Systems

  2024cites this paper
• Analytical techniques for screening of cannabis and derivatives from human hair specimens.

  2024cites this paper
• Development of new matrix reference materials for quantitative urine analysis in drug tests

  2024cites this paper
• Cannabis Use and Biomarkers of Inflammation, Immune Activation, and Microbial Translocation in Persons with HIV

  2024influential citation
• Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution

  2024cites this paper
• Associations between hair-derived cannabinoid levels, self-reported use, and cannabis-related problems

  2024cites this paper
• Abnormal structural covariance networks in young adults with recent cannabis use.

  2024cites this paper
• Associations Between Self‐Reported Cocaine Use Patterns and Cocaine and Its Metabolites in Hair: Implications for Clinical and Forensic Practices

  2024cites this paper
• Kannabis Kullanımının Epidemiyolojisi ve Farmakolojik Etkileri

  2024cites this paper
• Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation

  2024cites this paper
• Short: Precision Polysubstance Use Episode Detection in Wearable Biosensor Data Streams

  2023cites this paper
• On the challenges of hair testing to detect underreported substance use in research settings

  2023cites this paper
• Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies

  2023cites this paper
• Self-report methodology for quantifying standardized cannabis consumption in milligrams delta-9-tetrahydrocannabinol

  2023cites this paper
• Forensic toxicological analyses reveal the use of cannabis in Milano (Italy) in the 1600's

  2023cites this paper
• Determination of cannabinoids in human cerumen samples by use of UPLC-MS/MS as a potential biomarker for drug use.

  2023cites this paper
• Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study.

  2023cites this paper
• Driving under the influence of cannabis: A 5-year retrospective Italian study.

  2023cites this paper
• Comparison between Blood, Non-Blood Fluids and Tissue Specimens for the Analysis of Cannabinoid Metabolites in Cannabis-Related Post-Mortem Cases

  2023influential citation
• Enhanced cannabis timeline followback (EC-TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures.

  2023cites this paper
• A Review on the Impact of Cannabis in Society and the Analytical Methodologies for Cannabinoids

  2023cites this paper
• Concordance between substance use self-report and hair analysis in community-based adolescents

  2023cites this paper
• Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples, and drug product using HPLC-HRMS/MS.

  2023cites this paper
• Simple Method for the Determination of THC and THC-COOH in Human Postmortem Blood Samples by Gas Chromatography—Mass Spectrometry

  2023cites this paper
• Exploratory Growth Mixture Modeling of Cannabis-Withdrawal Syndrome Trajectories of Adult Pure Cannabis Dependents During Detoxification: Two Subtypes?

  2023cites this paper
• Use of computational toxicology tools to predict in vivo endpoints

  2022cites this paper
• Hair concentrations of Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in cannabis consumers psychiatric patients

  2022cites this paper
• Should Per Se Limits Be Imposed For Cannabis? Equating Cannabinoid Blood Concentrations with Actual Driver Impairment: Practical Limitations and Concerns

  2022cites this paper
• Hair concentrations of Δ-9-tetrahydrocannabinol and cannabidiol in cannabis consumers psychiatric patients

  2022cites this paper
• Bridging Disciplines: Applications of Forensic Science and Industrial Hemp

  2022cites this paper
• Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study

  2022cites this paper
• Analysis of conventional and nonconventional forensic specimens in drug-facilitated sexual assault by liquid chromatography and tandem mass spectrometry.

  2022cites this paper
• Prolonged detection of cannabis in urine of a consumer in a Forensic hospital, Victoria, Australia, up to 102 days of abstinence - A Case report

  2022cites this paper
• LC-MS/MS-MS3 for the Determination and Quantification of Δ9-Tetrahydrocannabinol and Metabolites in Blood Samples.

  2022cites this paper
• A Review of Associations between Externalizing Behaviors and Prenatal Cannabis Exposure: Limitations & Future Directions

  2022cites this paper
• Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents

  2022cites this paper
• Use of computational toxicology tools to predict in vivo endpoints associated with Mode of Action and the endocannabinoid system: A case study with chlorpyrifos, chlorpyrifos-oxon and Δ9Tetrahydrocannabinol

  2022cites this paper
• Affinity Assays for Cannabinoids Detection: Are They Amenable to On-Site Screening?

  2022cites this paper
• Cannabidiol in urine is not a proof of CBD consumption—lesson learned from urine sample analysis in routine caseworks

  2022cites this paper
• Forensic Toxicology of Typical Drugs in Drug-Facilitated Sexual Assault

  2022cites this paper
• Sensitive determination of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and complementary cannabinoids in hair using alkaline digestion and mixed-mode solid phase extraction followed by liquid-chromatography-tandem mass spectrometry.

  2021cites this paper
• Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction

  2021influential citation
• Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC) - results from urine drug testing in Sweden.

  2021cites this paper
• The Pharmacology of Cannabinoids

  2021cites this paper
• Analysis of cannabinoids in conventional and alternative biological matrices by liquid chromatography: Applications and challenges.

  2021cites this paper
• Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder

  2021cites this paper
• Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study.

  2021cites this paper
• Investigating predictive factors of dialectical behavior therapy skills training efficacy for alcohol and concurrent substance use disorders: A machine learning study.

  2021cites this paper
• Association between Alcohol, Substance Use, and Inpatient Burn Outcomes.

  2021cites this paper
• Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults

  2021cites this paper
• A mixed-methods study to inform the clarity and accuracy of cannabis-use and cannabis-tobacco co-use survey measures.

  2021cites this paper
• Les différents usages du cannabis : approche adaptée du biologiste toxicologue

  2021cites this paper
• A critical review on the detection, occurrence, fate, toxicity, and removal of cannabinoids in the water system and the environment

  2020cites this paper
• The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

  2020cites this paper
• Using sesame seed oil to preserve and concentrate cannabinoids for paper spray mass spectrometry

  2020cites this paper
• Quantitative Analysis of Cannabinoids in Whole Blood Using UPLC-MS/MS for Forensic Laboratories : Waters

  2020cites this paper
• Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study

  2020cites this paper
• Butyrylcholinesterase in Substance Abuse: An Overview

  2020cites this paper
• Monitoring the effects of perinatal cannabis and synthetic cannabinoid exposure.

  2020cites this paper
• Detectability of the Psychotropic Substance Cannabis in Head or Body Hair: Update of Forensic Criminalistics

  2020cites this paper
• Occupational Exposure to Secondhand Cannabis Smoke Among Law Enforcement Officers Providing Security at Outdoor Concert Events.

  2020influential citation
• Child Maltreatment and Cannabis: Intersection in Pediatric Emergency Department Visits

  2020cites this paper
• Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

  2020influential citation
• Characterization of Cannabidiol in Alternative Biological Specimens and Urine, After Consumption of an Oral Capsule.

  2020cites this paper
• Recent cannabis use is associated with smaller hippocampus volume: High‐resolution segmentation of structural subfields in a large non‐clinical sample

  2020cites this paper
• Using Sesame Seed Oil to Preserve and Preconcentrate Cannabinoids for Paper Spray Mass Spectrometry.

  2020cites this paper
• Butyrylcholinesterase in Substance Abuse: An Overview

  2020cites this paper
• Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence

  2020cites this paper
• Feasibility of dialectical behavior therapy skills training as an outpatient program in treating alcohol use disorder: The role of difficulties with emotion regulation and experiential avoidance

  2020cites this paper
• In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis

  2019cites this paper
• The therapeutic role of emotion regulation and coping strategies during a stand-alone DBT Skills training program for alcohol use disorder and concurrent substance use disorders.

  2019cites this paper
• Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders.

  2019cites this paper
• A review of bioanalytical techniques for evaluation of cannabis (Marijuana, weed, Hashish) in human hair

  2019cites this paper
• Topical review on monitoring tetrahydrocannabinol in breath

  2019cites this paper
• Developing a novel packed in-tube solid phase extraction method for determination ∆ 9-tetrahydrocannabinol in biological samples and cannabis leaves.

  2019cites this paper
• Strengths and limitations of two cannabis-impaired driving detection methods: a review of the literature

  2019cites this paper
• Self-Reported Use of Tobacco, E-cigarettes, and Marijuana Versus Urinary Biomarkers

  2019influential citation
• Cannabiskonsum zum Freizeitgebrauch

  2019cites this paper
• A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.

  2019cites this paper
• Evaluation of police officers' exposure to secondhand cannabis smoke at open-air stadium events.

  2019cites this paper
• LC‐MS application for therapeutic drug monitoring in alternative matrices

  2019cites this paper
• Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective

  2019cites this paper
• Detection of cannabinoids in hair after cosmetic application of hemp oil

  2019cites this paper
• Influence of cosmetic hair treatments on cannabinoids in hair: Bleaching, perming and permanent coloring.

  2019cites this paper
• Cannabinoids and Synthetic Cannabinoids

  2019cites this paper